Capricor Therapeutics (CAPR) Fails to deliver data

Key failure to deliver metrics for Capricor Therapeutics :

• Last SEC data release: 2025-12-31
• Last 15 days FTD volume: NZ$1.28 M
• Last 3 months FTD volume: NZ$67.49 M
• Last 12 months FTD volume: NZ$0.15 B

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Capricor Therapeutics (CAPR) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Capricor Therapeutics (CAPR) - since 2019

Capricor Therapeutics (CAPR) Failure to deliver volume, Year over Year

FTD volume in the last 3 months for similar companies or competitors

Company	FTD volume (3 months)	FTD volume (1 year)	Country
Cytokinetics CYTK	NZ$10.53 M	NZ$33.6 M	🇺🇸 USA
Palatin Technologies PTN	NZ$0.63 M	NZ$0.69 M	🇺🇸 USA
Johnson & Johnson JNJ	NZ$32.98 M	NZ$0.10 B	🇺🇸 USA
Neurocrine Biosciences NBIX	NZ$4.14 M	NZ$31.55 M	🇺🇸 USA
Celldex Therapeutics CLDX	NZ$6.56 M	NZ$11.6 M	🇺🇸 USA
Eterna Therapeutics ERNA	N/A	NZ$1.51 M	🇺🇸 USA